← Leaderboards
James F Cleary
University Of Wisconsin-Madison
$2,023,823
Attributed
$2,023,823
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $511.4K · FY2007–12$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$2,023,823 · 3
By mechanism
P50$1,337,546 · 1
P30$685,465 · 1
M01$812 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- Carey E Gleason$24,542,292
- Benjamin M Craig$3,801,643
- Todd David Molfenter$10,297,551
- Amy Trentham-Dietz$16,896,140
- Susan C Pitt$2,329,214
Others in their field
Top investigators on “Base”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$613,567,095
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Larry Arthur$521,411,998
- Leonard Freedman · Leidos Biomedical Research, Inc.$515,995,429
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$507,042,060
Research focus
BaseClinical TrialsMalignant NeoplasmsMonitorAffectResearch PersonnelResourcesSymptomsLeadCommunicationBehavioralChicagoComplexCancer BurdenAuthorityAdvanced Malignant NeoplasmClinical ResearchCancer TherapyBiometryCaregiversCaringChargeBereavementAdverse Effects
Grant awards (11)
ICCS in Lung Cancer: Evaluating Survival Benefits$212,840
P50 · FY2012 · CA · contact PI
ICCS in Lung Cancer: Evaluating Survival Benefits$298,540
P50 · FY2011 · CA · contact PI
Protocol Review and Monitoring$198,126
P30 · FY2011 · CA · contact PI
ICCS in Lung Cancer: Evaluating Survival Benefits$385,875
P50 · FY2010 · CA · contact PI
Protocol Review and Monitoring$125,475
P30 · FY2010 · CA · contact PI
ICCS in Lung Cancer: Evaluating Survival Benefits$287,963
P50 · FY2009 · CA · contact PI
Protocol Review and Monitoring$119,107
P30 · FY2009 · CA · contact PI
ICCS In Lung Cancer: Evaluating Survival Benefits$152,328
P50 · FY2008 · CA · contact PI
Protocol Review and Monitoring$117,757
P30 · FY2008 · CA · contact PI
Protocol Review and Monitoring$125,000
P30 · FY2007 · CA · contact PI
TREATMENT OF ARM LYMPHEDEMA IN BREAST CANCER SURVIVORS: PYCNOGENOL VS PLACEBO$812
M01 · FY2007 · RR · contact PI